CD-801
- Generic Name
- CD-801
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
- First Posted Date
- 2024-05-17
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 37
- Registration Number
- NCT06418659
- Locations
- 🇨🇳
Changzheng Hospital, Shanghai, Shanghai, China
A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 2
- Registration Number
- NCT06092112
- Locations
- 🇨🇳
Changzheng Hospital，Naval Medical University, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath